One of the major issues facing current cardiac stem cell therapies for preventing postinfarct heart failure is the low retention and survival rates of transplanted cells within the injured myocardium, limiting their therapeutic efficacy. Recently, the use of scaffolding biomaterials has gained attention for improving and maximizing stem cell therapy. The objective of this protocol is to introduce a simple and straightforward technique to transplant bone marrow-derived mesenchymal stem cells (MSCs) using injectable hydroxyphenyl propionic acid (GH) hydrogels; the hydrogels are favorable as a cell delivery platform for cardiac tissue engineering applications due to their ability to be cross-linked in situ and high biocompatibility. We present a simple method to fabricate MSC-loading GH hydrogels (MSC/hydrogels) and evaluate their survival and proliferation in three-dimensional (3D) in vitro culture. In addition, we demonstrate a technique for intramyocardial transplantation of MSC/hydrogels in mice, describing a surgical procedure to induce myocardial infarction (MI) via left anterior descending (LAD) coronary artery ligation and subsequent MSC/hydrogels transplantation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3791/61752 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An Alginate/Gelatin Injectable Hydrogel Containing Au Nanoparticles for Transplantation of Embryonic Mouse Cardiomyocytes in Myocardial Repair.
Macromol Biosci
December 2024
School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK.
Article Synopsis
Human platelet lysate combined with mesenchymal stem cells pretreated with platelet lysate improved cardiac function in rats with myocardial infarction.
Sci Rep
November 2024
Gastroenterology and Hepatology Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Article Synopsis
- * The study conducted on male Wistar rats compared the effects of several treatments (HPL, PMSCs, PMSC lysate, and their combinations) on cardiac function and recovery post-MI induced by LAD ligation.
- * Results showed that treatments with HPL and PMSCs improved blood pressure and cardiac function while also increasing the presence of cardiac cell markers, indicating HPL enhances the environment for heart cell recovery and differentiation from PMSCs.
A rare case of ventricular tachycardia caused by an intramyocardial fibroma with successful surgical resection in an adult.
J Cardiothorac Surg
September 2024
Department of Cardiology, Virginia Tech Carilion Roanoke Memorial Hospital, 1906 Belleview Ave SE, Roanoke, VA, 24015, USA.
Article Synopsis
- Cardiac fibromas are very rare in adults, with surgery being the preferred treatment, although alternatives like antiarrhythmic drugs and heart transplants exist.* -
- A case of a 42-year-old man revealed a large fibroma causing dangerous heart rhythms, which was diagnosed with imaging techniques and successfully removed through surgery.* -
- These tumors are well-defined and do not invade heart tissue, making surgical removal a viable option for treatment.*
Cellular heterogeneity of pluripotent stem cell-derived cardiomyocyte grafts is mechanistically linked to treatable arrhythmias.
Nat Cardiovasc Res
February 2024
Centre for Heart Research, the Westmead Institute for Medical Research, the University of Sydney, Westmead, New South Wales, Australia.
Article Synopsis
- - Preclinical studies show that human pluripotent stem cell-derived cardiomyocytes (PSC-CMs) can help repair injured hearts, with multiple clinical trials underway.
- - Ventricular arrhythmias (EAs) can occur after injecting PSC-CMs into the heart, linked to cellular diversity within the transplanted cells, particularly arrhythmogenic subpopulations like atrial and pacemaker-like cardiomyocytes.
- - Identifying specific surface markers may help differentiate risky PSC-CMs from safer ones, and both drug treatments and other interventions can help manage or eliminate these arrhythmias in the experimental model used.
Mesenchymal Stem Cells Increase Resistance Against Ventricular Arrhythmias Provoked in Rats with Myocardial Infarction.
Stem Cell Rev Rep
November 2024
Laboratory of Physiology and Cardiac Pathophysiology, Department of Medicine, Federal University of São Paulo, São Paulo, SP, Brazil.
This study evaluated the role of the mesenchymal stem cells derived from adipose tissue (MSCs) in provoked ventricular arrhythmias (VAs) in animals with myocardial infarction (MI). The experimental groups were: sham, subjected to sham surgery and intramyocardial saline injection; MIV, infarcted rats subjected to intramyocardial saline injection; MI + MSCs, infarcted rats subjected to intramyocardial MSCs injection. Injections were performed two days after infarction and the arrhythmogenic inducibility experiment was performed the next day.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!